首页> 外文OA文献 >Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System

【2h】

Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System

机译：蛋白酶体抑制剂的抗癌疗法概述：硼卓和第二代蛋白酶体抑制剂对泛素 - 蛋白酶体系的未来产生抑制剂的透视

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Q. Dou; Jeffrey Zonder;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类
入库时间 2022-08-20 22:05:12

相似文献

外文文献
中文文献
专利

1. Overview of proteasome inhibitor-based anti-cancer therapies: Perspective on Bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system [J] . Current cancer drug targets . 2014,第6期

机译：基于蛋白酶体抑制剂的抗癌治疗概述：硼替佐米和第二代蛋白酶体抑制剂与泛素-蛋白酶体系统的下一代抑制剂的前景
2. Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy. [J] . Dick LR, Fleming PE Drug discovery today . 2010,第5a6期

机译：建立在硼替佐米上：第二代蛋白酶体抑制剂作为抗癌治疗。
3. Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy. [J] . Dick LR, Fleming PE Drug discovery today . 2010,第5a6期

机译：在Bortezomib上建立：第二代蛋白酶体抑制剂作为抗癌治疗。
4. Nonclinical Discovery and Development of Bortezomib (PS-341, VELCADE~(R)) a Proteasome Inhibitor for the Treatment of Cancer [C] . Bouchard PR, Juedes M, Nix D, Annual Meeting of the American Society for Veterinary Clinical Pathology . 2004

机译：Bortezomib（PS-341，Velcade〜（R）的非临床发现和发展）一种治疗癌症的蛋白酶体抑制剂
5. The Design and Synthesis of Novel Proteasome Inhibitors: Studies on the Synthesis of Nagelamide M and Analogs, the Synthesis of Rapamycin Based Proteasome Inhibitors, and the Synthesis of TCH Based Molecular Probes for Binding Site Determination. [D] . Giletto, Matthew Basil. 2017

机译：新型蛋白酶体抑制剂的设计与合成：Nagelamide M和类似物的合成，雷帕霉素基蛋白酶体抑制剂的合成以及TCH基分子探针的结合位点测定的研究。
6. Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System [O] . Q. Ping Dou, Jeffrey A. Zonder -1

机译：基于蛋白酶体抑制剂的抗癌治疗概述：硼替佐米和第二代蛋白酶体抑制剂与泛素-蛋白酶体系统的下一代抑制剂的观点
7. THE SECOND GENERATION PROTEASOME INHIBITOR CARFILZOMIB INTERACTS SYNERGISTICALLY WITH HDAC INHIBITORS IN DIFFUSE LARGE B-CELL LYMPHOMA CELLS THROUGH MULTIPLE MECHANISMS AND CIRCUMVENTS BORTEZOMIB RESISTANCE [O] . Lembersky Dmitry 2009

机译：第二代抑菌剂卡非昔布与HDAC抑制剂协同作用，通过多种机制和环孢菌抗性扩散了大型B细胞淋巴瘤细胞

Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System

著录项

相似文献

相关主题

期刊订阅